These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37306819)

  • 21. Cerebral Cavernous Malformations, Developmental Venous Anomaly, and Its Coexistence: A Review.
    Idiculla PS; Gurala D; Philipose J; Rajdev K; Patibandla P
    Eur Neurol; 2020; 83(4):360-368. PubMed ID: 32731220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple cerebral cavernous malformations: Clinical course of confirmed, assumed and non-familial disease.
    Santos AN; Rauschenbach L; Saban D; Chen B; Darkwah Oppong M; Herten A; Gull HH; Rieß C; Deuschl C; Schmidt B; Jabbarli R; Wrede KH; Zhu Y; Frank B; Sure U; Dammann P
    Eur J Neurol; 2022 May; 29(5):1427-1434. PubMed ID: 35060255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
    Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
    World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding propensity of cavernous malformations: impact of tight junction alterations on the occurrence of overt hematoma.
    Jakimovski D; Schneider H; Frei K; Kennes LN; Bertalanffy H
    J Neurosurg; 2014 Sep; 121(3):613-20. PubMed ID: 25014440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemorrhage owing to cerebral cavernous malformation: imaging, clinical, and histopathological considerations.
    Kurihara N; Suzuki H; Kato Y; Rikimaru H; Sato A; Uenohara H
    Jpn J Radiol; 2020 Jul; 38(7):613-621. PubMed ID: 32221793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cavernous Malformations to Be Investigated for Familiarity: The Role of Ki67 MIB1.
    Maiuri F; Mariniello G; Corvino S; Somma T; Guadagno E; Teodonno G; Del Basso De Caro M; Cappabianca P
    World Neurosurg; 2021 Nov; 155():e75-e82. PubMed ID: 34389524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemorrhage from cerebral cavernous malformations: The role of associated developmental venous anomalies.
    Chen B; Herten A; Saban D; Rauscher S; Radbruch A; Schmidt B; Zhu Y; Jabbarli R; Wrede KH; Kleinschnitz C; Sure U; Dammann P
    Neurology; 2020 Jul; 95(1):e89-e96. PubMed ID: 32513786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study.
    Josephson CB; Leach JP; Duncan R; Roberts RC; Counsell CE; Al-Shahi Salman R;
    Neurology; 2011 May; 76(18):1548-54. PubMed ID: 21536634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype.
    Petersen TA; Morrison LA; Schrader RM; Hart BL
    AJNR Am J Neuroradiol; 2010 Feb; 31(2):377-82. PubMed ID: 19833796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seasonal variation in hemorrhage and focal neurologic deficit due to intracerebral cavernous malformations.
    Flemming KD; Brown RD; Link MJ
    J Clin Neurosci; 2015 Jun; 22(6):969-71. PubMed ID: 25769259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of cerebral cavernous malformations in children.
    Gross BA; Du R; Orbach DB; Scott RM; Smith ER
    J Neurosurg Pediatr; 2016 Feb; 17(2):123-128. PubMed ID: 26474098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of propranolol for treatment of familial cerebral cavernous malformations (Treat_CCM): a randomised, open-label, blinded-endpoint, phase 2 pilot trial.
    Lanfranconi S; Scola E; Meessen JMTA; Pallini R; Bertani GA; Al-Shahi Salman R; Dejana E; Latini R;
    Lancet Neurol; 2023 Jan; 22(1):35-44. PubMed ID: 36403580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebral Cavernous Malformation: What a Practicing Clinician Should Know.
    Flemming KD; Lanzino G
    Mayo Clin Proc; 2020 Sep; 95(9):2005-2020. PubMed ID: 32605781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of radiation-induced cavernous malformations and comparison with a nonradiation cavernous malformation cohort.
    Cutsforth-Gregory JK; Lanzino G; Link MJ; Brown RD; Flemming KD
    J Neurosurg; 2015 May; 122(5):1214-22. PubMed ID: 25699412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How Relevant Is Occlusion of Associated Developmental Venous Anomaly in Cerebral Cavernoma Surgery? A Clinical and Radiographic Comparison Study.
    Tantongtip D; Spetzger U; Arnold S; von Schilling A; Kiriyanthan G
    J Neurol Surg A Cent Eur Neurosurg; 2016 Mar; 77(2):111-7. PubMed ID: 26444962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebellar cavernous malformation in pediatric patients: defining clinical, neuroimaging, and therapeutic characteristics.
    Knerlich-Lukoschus F; Steinbok P; Dunham C; Cochrane DD
    J Neurosurg Pediatr; 2015 Sep; 16(3):256-66. PubMed ID: 26053436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gamma knife radiosurgery for symptomatic brainstem intra-axial cavernous malformations.
    Park SH; Hwang SK
    World Neurosurg; 2013 Dec; 80(6):e261-6. PubMed ID: 23010066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International multicenter cohort study of pediatric brain arteriovenous malformations. Part 2: Outcomes after stereotactic radiosurgery.
    Starke RM; Ding D; Kano H; Mathieu D; Huang PP; Feliciano C; Rodriguez-Mercado R; Almodovar L; Grills IS; Silva D; Abbassy M; Missios S; Kondziolka D; Barnett GH; Dade Lunsford L; Sheehan JP
    J Neurosurg Pediatr; 2017 Feb; 19(2):136-148. PubMed ID: 27911249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguishing mimics from true hemorrhagic cavernous malformations.
    Kumar S; Brinjikji W; Lanzino G; Flemming KD
    J Clin Neurosci; 2020 Apr; 74():11-17. PubMed ID: 31982281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation.
    Dammann P; Wrede K; Jabbarli R; Neuschulte S; Menzler K; Zhu Y; Özkan N; Müller O; Forsting M; Rosenow F; Sure U
    J Neurosurg; 2017 Apr; 126(4):1303-1311. PubMed ID: 27367244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.